The process of challenging your body, pushing through resistance, and achieving new levels of strength can significantly reduce stress, anxiety, and depression
The ADJUNCT ONE trial found that symptomatic hypoglycemia had a dose-related effect with a rate ratio between 1.27 and 1.31 on doses of 1.2 and 1.8 mg of liraglutide, respectively
GLP-1 therapies offer tangible treatment options for patients like these, as the SELECT trial showed a 20% reduction in cardiovascular risk in patients who were obese or overweight but not diabetic
The TRIUMPH-1 trial reports mild results at lower doses which are tolerated well, yet this medication is unsuitable for those with specific health histories, such as medullary thyroid cancer
Many women find this approach beneficial for addressing concerns such as nutritional deficiencies, mood swings, or PMS and menopausal symptoms